Drawing for GYNI

USPTO serial 88335958

GYNI

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
Examiner
HSU, FONG
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with GYNI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Medical diagnostic reagents and assays for testing bodily fluids for microorganisms; medical diagnostic reagents and assays for testing bodily fluids for use in the detection, diagnosis, management, and treatment of gynecological conditions; medical diagnostic reagents and assays for testing bodily fluids for use in the detection, diagnosis, management, and treatment of gynecological conditions, namely, vaginitis, STDs, and other feminine medical disorders; diagnostic kits comprised of medical diagnostic reagents and assays for testing bodily fluids for microorganisms; diagnostic kits comprised of medical diagnostic reagents and assays for testing bodily fluids for use in the detection, diagnosis, management, and treatment of gynecological conditions; and diagnostic kits comprised of medical diagnostic reagents and assays for testing bodily fluids for use in the detection, diagnosis, management, and treatment of gynecological conditions, namely, vaginitis, STDs, and other feminine medical disordersACTIVE
009Downloadable mobile applications featuring medical information for use by female patients and healthcare service providers for obtaining gynecological informationACTIVE
010Medical devices and instruments for obtaining female patient specimens; medical devices and instruments for obtaining female patient specimens for use in the detection, diagnosis, management, and treatment of gynecological conditions; disposable medical devices and instruments for obtaining female patient specimens; disposable medical devices and instruments for obtaining female patient specimens for use in the detection, diagnosis, management, and treatment of gynecological conditions; medical devices and instruments, namely, probes for medical purposes, medical trays, and diagnostic kits consisting primarily of probes, buffers and reagents for microbial testing, for obtaining female patient specimens; medical devices and instruments, namely, probes for medical purposes, medical trays, and diagnostic kits consisting primarily of probes, buffers and reagents for microbial testing, for obtaining female patient specimens for use in the detection, diagnosis, management, and treatment of gynecological conditions; disposable medical devices and instruments, namely, probes for medical purposes, medical trays, and diagnostic kits consisting primarily of probes, buffers and reagents for microbial testing, for obtaining female patient specimens; disposable medical devices and instruments, namely, probes for medical purposes, medical trays, and diagnostic kits consisting primarily of probes, buffers and reagents for microbial testing, for obtaining female patient specimens for use in the detection, diagnosis, management, and treatment of gynecological conditions; laboratory equipment and supplies, namely, optical scanners, computers, spectroscopes, microscopes, microscope slides, test tubes, centrifuges, centrifuge tubes, incubators, pipettes, syringes, and laboratory mixers, for analyzing female patient specimens for use in the detection, diagnosis, management, and treatment of gynecological conditionsACTIVE
044Consultation services in the field of medical care relating to the detection, diagnosis, management, and treatment of gynecological conditionsACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Apr 10, 2023MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 10, 2023ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 31, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 30, 2022EX5GSOU EXTENSION 5 GRANTED
Aug 30, 2022AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 18, 2022EXT5SOU EXTENSION 5 FILED
Aug 18, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 8, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 6, 2022EX4GSOU EXTENSION 4 GRANTED
Jan 6, 2022EXT4SOU EXTENSION 4 FILED
Jan 6, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 5, 2022CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 5, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 5, 2022ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jan 5, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 5, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 5, 2022COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 9, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 7, 2021EX3GSOU EXTENSION 3 GRANTED
Sep 7, 2021EXT3SOU EXTENSION 3 FILED
Sep 7, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 9, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 5, 2021EX2GSOU EXTENSION 2 GRANTED
Mar 5, 2021EXT2SOU EXTENSION 2 FILED
Mar 5, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 15, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 13, 2020EX1GSOU EXTENSION 1 GRANTED
Aug 13, 2020EXT1SOU EXTENSION 1 FILED
Aug 13, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 10, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 14, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 14, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 25, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 10, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Nov 25, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Nov 25, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 22, 2019ALIEASSIGNED TO LIE
Nov 18, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 29, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 29, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 29, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 21, 2019DOCKASSIGNED TO EXAMINER
Mar 29, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 15, 2019NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance